How many patents does
Cytomx Therapeutics have?
patents
337
families
28
granted
50
applications
287
US
84
WO
43
EP
31
JP
25
CN
19
KR
11
GB
2
RoW
122
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Cytomx Therapeutics
Top ten assignees appearing on patents
2009 - 2018
| cytomx therapeutics | 251 |
| cytomx | 5 |
| bristol-myers squibb company | 3 |
| cytomx therapetuics | 3 |
2009
| cytomx | 4 |
| cytomx therapeutics | 2 |
Cytomx Therapeutics
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| modified antibody compositions, methods of making and using thereof | 34 | 2009 |
| activatable antibodies that bind epidermal growth factor receptor and methods of use the… 🛈 | 30 | 2012 |
| anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-jagged antibodies and… 🛈 | 26 | 2012 |
| activatable binding polypeptides and methods of identification and use thereof | 22 | 2007 |
| proproteins and methods of use thereof | 22 | 2009 |
| anti-pdl1 antibodies, activatable anti-pdl1 antibodies, and methods of use thereof | 15 | 2015 |
| anti-cd71 antibodies, activatable anti-cd71 antibodies, and methods of use thereof | 15 | 2015 |
| matriptase and u-plasminogen activator substrates and other cleavable moieties and metho… 🛈 | 14 | 2014 |
| matrix metalloproteinase substrates and other cleavable moieties and methods of use ther… 🛈 | 14 | 2013 |
| multispecific antibodies, multispecific activatable antibodies and methods of using the … 🛈 | 14 | 2013 |